Aftereffect

An aftereffect is the phase that follows a substance's primary action — the state a person inhabits once the acute effects have largely subsided but before they have returned to their ordinary baseline. It regularly has a character of its own: fatigue, low mood, cognitive fog, lingering stimulation, or disrupted sleep, depending on the substance and the individual.

It is worth separating aftereffects from two related ideas. A rebound effect is the temporary return of a symptom the drug had been suppressing — heightened anxiety as a sedative clears, for example. An aftereffect need not involve any prior suppression; it is simply what remains once the primary phase ends. Withdrawal is a separate phenomenon that arises from physical dependence formed through repeated use.

Because duration figures on substance pages typically describe the acute phase, they often understate how long a day is actually affected. A stimulant listed as lasting four to six hours may be followed by several hours of fatigue and flat mood that the figure does not capture.

How it works · its role

Aftereffects are produced by the same neurochemical events that drive a substance's primary action, but on a different timescale. Many psychoactive drugs work by flooding or depleting neurotransmitter pools, or by pushing receptors into compensatory states; the nervous system then spends time correcting for this.

A stimulant that floods the synapse with dopamine and norepinephrine leaves those stores temporarily depleted as it clears, producing the characteristic crash: tiredness, flattened motivation, and sometimes low mood. MDMA triggers a large release of serotonin; the hours and days that follow often involve diminished serotonergic tone, correlating with fatigue and subdued emotion in proportion to the dose.

Disrupted sleep architecture is another common driver. Stimulants, psychedelics, and empathogens all tend to delay sleep onset and reduce slow-wave and REM sleep even after wakefulness feels normal — and poor sleep amplifies every other residual effect the next day.

Relevance to substances & effects

The character of an aftereffect tracks closely with a substance's mechanism. Stimulants and empathogens — amphetamines, cocaine, MDMA — tend to produce sedative, low-mood aftereffects proportional to the intensity of the acute phase; higher doses generally mean harder landings.

Classic psychedelics such as LSD and psilocybin produce a different pattern. The day following a psychedelic session frequently involves tiredness but also a period commonly described as an afterglow — heightened clarity, emotional openness, or a quiet sense of calm that can persist for days. This is thought to relate to sustained neuroplastic signalling rather than simple neurotransmitter depletion.

Cannabis and alcohol offer familiar examples at lower intensity. Alcohol's hangover — headache, nausea, fatigue, cognitive impairment — is one of the most studied aftereffects, driven by dehydration, acetaldehyde accumulation, and disrupted sleep. Cannabis next-day effects are more variable, tending toward cognitive fog and mild fatigue, particularly after high doses.

For practical purposes, the aftereffect window is relevant when timing decisions about driving, operating machinery, or returning to demanding cognitive work. The acute phase ending is not the same as returning to baseline.